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ABSTRACT 
Objective: The main objective of the research work was to optimize the water requirement/content used in kneading method for solid 
dispersion/inclusion complex formation between water insoluble drug and polymer.  
Methods: Nimesulide (model drug) and β-cyclodextrin were taken in a different ratio such as 1:1, 1:3 and 1:5 and, the mixture was triturated well 
for half hour. Water was incorporated to the mixture in different levels like 75%, 50%, 25% w/v in divided proportions and 0% (no water addition, 
but the mixture was triturated continuously). After each part of water addition, the mixture was triturated well for 10 min and dried using hot air 
over for 30 min at 50 °C and sieved using sieve no: 44. The complexes formed were subjected for various analytical characterization studies 
including solubility, particle size, the angle of repose, tapped density, Carr’s index, fourier transform infrared spectrometry (FTIR), thermo 
gravimetric-differential thermal analysis (TG-TDA), x-ray diffraction (XRD) studies and in vitro dissolution studies.  
Results: The dissolution studies showed improvement in the release of nimesulide, which depended on the percentage level of water. The solubility 
of the sample was increased with increasing the concentration of the inclusion complex formed. Kneading method was proved to be a successful 
technique for formation of stable inclusion complex of nimesulide with β-cyclodextrin. All the formulations exhibited acceptable particle size and 
solubility in the range of 22.6±2 to 29±5 and 45±5 to 133±3.5 respectively.  
Conclusion: Nimesulide and β-cyclodextrin complex was successfully prepared and characterized for the drug-polymer stability and interactions. 
The result confirmed that the liquid content in the solid dispersion prepared by the kneading method played an important role in the dissolution of 
the poorly soluble drug.  
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Nimesulide (NM) is one of the potent non-steroidal anti-
inflammatory drugs (NSAIDs), widely prescribed for various anti-
inflammatory conditions. NM has categorized under class II drugs of 
the biopharmaceutical classification system (BCS) that illustrate 
poor aqueous solubility, which is the main reason for its low and 
variable oral bio availability [1-3]. NM is an acidic drug that differs 
from many similar compounds, by virtue of the presence of 
sulfoanilide group rather than a carboxyl group. Chemically it is 
named as [4-nitro-2-(phenoxy) methane sulphoanilide] (fig. 1). 
 
 
Fig. 1: Structure of nimesulide [2] 
 
Pharmacologically NM is an inhibitor of cyclo-oxygenase-2 (COX-2) 
enzyme, and hence inhibits the synthesis of critical prostaglandins 
and spares cytoprotective prostaglandins. It can also inhibit the 
process involved in platelets aggregation [4-6]. 
The oral absorption of NM is dissolution rate limited, and hence 
enhancement in solubility and dissolution rate is required for 
increasing its oral bioavailability [7]. Among different methods 
reported for improving the solubilization of NM, the formation of an 
inclusion complex with cyclodextrins (CDs) (fig. 2) has been 
identified as the most common and successful approach. CDs exhibit 
a hydrophilic outer surface and lipophilic inner cavity with a cyclic 
torus shape, which is capable of interacting with a large variety of 
guest molecules to form an inclusion complex. CDs are commonly 
used in drug formulations as solubility enhancers because of their 
ability to form water soluble complexes with poorly water soluble 
drugs. They also have huge potential as carrier molecules in the 
formulation of novel drug delivery systems. The inclusion complexes 
can modify pharmacokinetic properties of guest molecules by fitting 
within the hydrophobic cavity of CDs [8, 9]. Several NSAIDs have 
been complexed with CDs, which resulted in high solubility and 
dissolution rate, decreased side effects, reduced dose, improved 
bioavailability and stability, lesser gastric irritation and also 
enhanced the palatability of the active molecules [10-13].  
 
 
Fig. 2: Structure of β-cyclodextrin [12] 
 
Kneading is one of the common methods used in solid dispersion 
technique for the enhancement of solubility and dissolution rate of 
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poorly soluble drugs. The process involves reduction of particle size 
at the molecular level through complexation of the freely water 
soluble chemically inert carriers with the guest molecule (drug). The 
formed product could result in better therapeutic effect due to 
improved solubility and increased bioavailability. During the kneading 
process, the addition of few drops of water to the triturated drug and 
inert polymer mixture helps in complete complexation between drug 
and polymer. The addition of water aids in dissolving the freely water 
soluble carrier which allows the drug to enter into the molecular domain, 
followed by trituration helps in reducing particle size up to sub-micron 
level. Thus, the combination of complexation and size reduction may 
double the effect for the enhancement of solubility [14, 15]. The aim of 
the present study was to prepare NM complexes with CDs by kneading 
method and study the effect of water level added in the solid dispersion 
process for the enhancement of solubility of the drug.  
MATERIALS AND METHODS  
Materials 
Nimesulide was purchased from Chatan and Chatan Ltd., Chennai, 
India. β-cyclodextrin was procured from SD Fine Chem Ltd., Mumbai, 
India. All other chemicals and reagents used were of analytical grade. 
Methods 
Nimesulide and β-cyclodextrin were taken in different ratios such as 
1:1, 1:3, 1:5 (table 1) and triturated well for uniform mixing of the 
powders. Water was added in different concentration as 25%, 50%, 
and 75% w/v to study the optimized level of water content required 
in the kneading process. In each ratio of the mixture, one batch was 
needed without the addition of water. The required amount of total 
water was divided into proportionate parts and added to the powder 
mixture at periodic intervals of 10 min. After each addition of water, 
the mixture was triturated uniformly for 30 min and dried [16]. At 
the end of the final addition of water, the mixture was further dried 
and then sieved using sieve no: 44. The prepared complex samples 
were stored at ambient conditions for further studies. 
Particle size analysis of the kneaded mixture  
The particles size and distribution of all the formulations were 
analysed by optical microscope method. The formulated kneaded 
dry powder sample was placed over a clean glass slide and focused 
at 10X and 40X magnifications to view the particles. The size of the 
particles was measured with an eye piece micrometer previously 
calibrated using the stage micrometer [17]. 
  
Table 1: Optimization of water in kneading method for nimesulide and β-cyclodextrin complexation 
S. No. Formulation code Drug (g) Carrier (g) Water (% w/v) 
1 KN1 1 1 25 
2 KN2 1 1 50 
3 KN3 1 1 75 
4 KN4 1 1 NW 
5 KN5 1 3 25 
6 KN6 1 3 50 
7 KN7 1 3 75 
8 KN8 1 3 NW 
9 KN9 1 5 25 
10 KN10 1 5 50 
11 KN11 1 5 75 
12 KN12 1 5 NW 
13 PT13 1 - - 
14 NP14 1 - - 
KN 1-12–Kneaded complex of nimesulide and cyclodextrin, NW–No Water added, NP–Nimesulide pure drug (unprocessed) and PT–Nimesulide pure 
drug in triturated form 
  
Physical and derived properties of kneaded mixture 
Angle of repose 
In order to evaluate the flow properties of the formulations 
prepared by the kneading method, angle of repose, bulk density, tap 
density and Carr’s index were calculated.  
Angle of repose (ϴ) was determined using funnel method to assess the 
flow behaviour of the sample. The powder sample was poured through a 
funnel placed at the height of about 3 cm from the base plane and 
allowed to form a heap. The height and diameter of the formed heap 
were noted and angle of repose was calculated using the formula [18]. 
ϴ = tan-1  
Where, h = height: r = radius of the heap. The experiment was conducted 
in triplicate and the mean±standard deviation was estimated. 
Bulk density 
The triturated final sample was accurately weighed and poured into 
a clean, dry measuring cylinder and the bulk volume was noted. The 
cylinder was then tapped 300 times from a constant height and the 
tapped volume was recorded. The bulk density and tapped density 
were calculated with respect to the known weight of the sample 




Carr's index is a measure to indicate the nature of the sample and its 
suitability to convert as tablets by tablet compression process. The 
stability and dose specificity of the kneading mixture could be 
improved by formulating as tablets. Carr’s index was calculated from 
the values of bulk density and tapped density of the formulation 
using the formula [19]. 
 
Solubility test 
The solubility of the kneaded samples was analysed and compared 
to the pure drug, by shake flask method using the thermostatic 
shaker. About 1 mg of NM and the kneaded mixture was placed in 5 
ml sample tube and 2 ml of distilled water was added to each 
separately. The tubes were placed on the shaker and continued 
shaking (Incubator shaker Edison, NJ, USA) for 24 h at 150 rpm at 
room temperature. The samples were taken out and then 
centrifuged at 4500 rpm at 4 °C for 10 min. The supernatant of each 
sample was collected separately, suitably diluted and the 
concentration of drug was measured using UV spectrophotometer 
(Evolution 201, Thermo Scientific, USA) at 397 nm [20]. 
Vedha et al. 
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In vitro dissolution studies 
The rate of drug dissolution from the formulated solid dispersion 
was studied by USP dissolution method. The powder samples were 
dried and sieved and then filled in hard gelatin capsule shells (size 
no. 1). The capsules were placed in the basket of USP type–I 
dissolution apparatus (Lab India, Mumbai) containing 900 ml of 
distilled water as the media. The dissolution set up was maintained 
at 50 rpm speed and 37 °C±2 °C for 60 min. At predetermined time 
intervals such as 10, 20, 30, 40, 50 and 60 min, the samples were 
withdrawn and the media was replaced with warm fresh distilled 
water after each withdrawal, to maintain the sink conditions. The 
collected samples were suitably diluted and the concentration of 
drug was measured using UV-visible spectrophotometer at 397 nm 
[20] using distilled water as the blank. The cumulative amount of 
drug released at each time point was calculated using the linear 
standard calibration curve method. The experiment was conducted 
in triplicate and the mean±standard deviation was recorded. 
Powder X-ray diffraction 
Samples of NM-CD complex prepared by kneading method with 
different levels of water were evaluated by X-ray powder diffraction 
analysis. The pure NM and kneaded samples were individually 
loaded in the sample cavity of the X-ray diffractometer (Ultima-3, 
Rigaku) and the diffraction patterns were obtained using with Cu 
radiation. The system was used with diverging and receiving slits of 
1 and 0.1 mm, respectively. The pattern was observed with 40 kV of 
tube voltage and 30 mA of tube current and scanned over the 2θ 
range of 10 °- 80 ° [21].  
Drug content 
The accurately weight quantity of kneaded powder sample was 
taken equivalent to the drug dose filled in a capsule and dissolved in 
50 ml of methanol. The sample was diluted suitably and the 
absorbance was measured using UV-visible spectrophotometer at 
397 nm. The percentage of drug content was calculated by using the 






Fourier transforms infrared spectroscopy (FTIR) 
FTIR (Perkin-Elmer system 200 FT-IR spectrophotometer) analysis 
was performed in order to find out the interaction between the drug 
and the polymers and thus the stability of drug could be confirmed. 
IR analysis of the sample reveals the presence of the characteristic 
functional group in the pure samples and the possible interaction in 
the mixture samples that could be compared to the original 
spectrum. It was performed by KBr pellet technique in which the 
samples were mixed with previously dried, saturated potassium 
bromide, and then pressed under a hydraulic pressure of 150 
kg/cm2 to form thin transparent disc pellet. The disc was placed in 
the IR sample holder and scanned over a range of 3600 to 400 cm-1 
at ambient temperature [22, 23]. 
Thermal analysis 
The thermal characteristics of the samples were analysed using 
thermo gravimetric and differential thermal analysis (TG-DTA) (SDT 
Q600 V20.9 Build 20). About 10 mg of the sample was placed in 
aluminium pan and then heated under nitrogen flow (20 ml/min) [24], 
at the rate of 10 °C/min within a range of 0 °C to 500 °C. TGA is one of 
the thermal analysis techniques used to characterise a wide variety of 
materials, which provides complimentary and supplementary 
information like differential scanning calorimetry (DSC) [25]. The 
technique can analyze materials that exhibit either mass loss or gain 
due to decomposition, oxidation or loss of volatiles [26, 27].  
RESULTS AND DISCUSSION 
Particle size analysis 
The particle size of the formulations prepared by kneading method 
was analysed using an optical microscope and reported in table 2. 
The maximum number of particles in the kneaded complex was 
observed to be in the narrow size range of 22 to 29 µm. There was 
no significant difference in the particle size of the pure drug with 
respect to the unprocessed sample (NP14-23.4 µm) and the kneaded 
sample (PT13-22.6 µm). In case of the NM-CD complex mixture, the 
addition of water had played a notable role in size reduction of the 
samples. The sample prepared with 1:1, 1:3 and 1:5 ratio without 
the addition of water (NW) have shown slightly larger sized particles 
in the range of 26–29 µm, whereas the water kneaded complex 
showed comparatively lesser size in each set of batches. This could 
be due to the easier solubilization of the carrier to the molecular 
level by the addition of water and kneading, which reduced the size 
and increased the effective surface area followed by the 
incorporation of the insoluble drug to form the inclusion complex. 
Solubility test 
Solubility test results are shown in table 2. The solubility of the 
unprocessed pure drug was 45.34 mg/ml, whereas the triturated 
drug showed slightly higher solubility as 52.5 mg/ml. In case of the 
NM-CD complex, there was a significant increase in the solubility of 
the drug compared to the pure drug, with minimum solubility range 
as 72.5 mg/ml and maximum up to 153.75 mg/ml. Although there 
was a notable increase in the solubility of a kneaded complex of NM-
CD (KN4, KN8 and KN12) without the addition of water (NW) 
compared to the pure drug, the solubility was still lesser than the 
kneading complex samples containing water. When the kneaded 
complex prepared with the addition of different levels of water (25%, 
50%, 75% w/v) were compared within each respective batches, the 
samples containing 50% w/v water was found to have optimum higher 
solubility. The increase in water addition to next level of 75% w/v could 
not increase the solubility of drug further, which may be due to the 
saturation solubility level of the formed complex of NM with CD. 
Drug content 
The drug content assay for all the solid dispersion was within the 
pharmacopeia limits of around 95-110%, as shown in table 2. 
  
Table 2: Solubility, particle size and drug content of the formulations 
 S. No. Formulation code  Solubility (mg/ml) Particle size (µm) Assay (%) 
1 KN1 72.5±5 23.8±1.5 105.9±1 
2 KN2 91.5±3 24.2±2 102.7±3 
3 KN3 79.25±5.5 24.6±4 95.9±4 
4 KN4 68±2.5 26.2±3 95.4±5 
5 KN5 95.25±5 26.6±8 96.1±2 
6 KN6 130.75±9 24.2±6 106±4 
7 KN7 107.25±4 26.4±2 109.4±1 
8 KN8 86±5.6 29.8±5 96.9±5 
9 KN9 118.25±5 24.6±4 95.5±4 
10 KN10 133.75±3.5 25.8±3 97.7±2.5 
11 KN11 124.25±10 23.8±2 95.6±53 
12 KN12 103.75±3.8 29±5 110±1 
13 PT13 52.5±4 22.6±2 97.6±4 
14 NP14  45.34±5 23.4±3 96.8±3 
KN 1-12–Kneaded complex of nimesulide and cyclodextrin, NP–Nimesulide pure drug (unprocessed) and PT–Nimesulide pure drug in triturated 
form. The data is given as mean±SD (n=3) 
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The flow properties of the kneaded formulations were calculated by 
using the angle of repose, bulk density, tap density and Carr’s index 
(table no. 3) and compared with the pure drug. Bulk property of the 
powders depends on inter particulate interaction, which interferes 
with the powder flow behaviour [28]. The unprocessed pure drug 
exhibits poor flow behaviour because of excessive cohesive forces 
and non-uniform particle size. However, the triturated pure drug has 
shown better flow property. Similarly, in case of the kneaded 
mixture without the addition of water, the angle of repose value 
was>30, which indicated poor flow due to the improper complex 
formation and non-uniform distribution of the drug in the carrier. In 
case of the kneaded complex with the addition of water, the angle of 
repose<30 indicated good flow property, wherein water played an 
important role for the formation of uniform inclusion complex [29, 
30]. Accordingly, the tapped density, bulk density and Carr’s index 
were observed to be suitable for processing the complex mixture 
into a single unit solid dosage form like tablets by compression 
process or filling as a compact powder in capsules. 
 
Table 3: Physical properties of NM-CD kneaded samples compared to pure drug 
S. No. Formulation code Angle of repose (ϴ) Tapped density (gm/ml) Bulk density (gm/ml) Carr’s index 
1 KN1 15±0.331 0.617±0.046 0.273±0.005 55.33±4.11 
2 KN2 16±0.816 0.695±0.057 0.277±0.023 59.33±5.73 
3 KN3 16±0.209 0.565±0.021 0.328±0.027 41.66±6.24 
4 KN4 31±0.500 0.62±0.023 0.314±0.012 49.13±4.05 
5 KN5 30±0.318 0.601±0.026 0.338±0.008 43.50±3.53 
6 KN6 30±0.723 0.563±0.046 0.359±0.019 36.00±2.12 
7 KN7 30±0.828 0.66±0.066 0.357±0.036 45.33±3.99 
8 KN8 38±0.789 0.592±0.026 0.305±0.013 45.00±4.08 
9 KN9 28±0.546 0.659±0.021 0.417±0.016 36.70±0.56 
10 KN10 27±0.424 0.065±0.021 0.506±0.126 36.77±1.25 
11 KN11 25±0.942 0.702±0.024 0.466±0.013 33.53±3.98 
12 KN12 46±0.834 0.658±0.021 0.363±0.027 44.63±5.25 
13 PT13 13±0.236 0.633±0.047 0.266±0.018 23.73±3.43 
14 NP14 42±1.220 0.429±0.017 0.537±0.026 19.94±3.62 
KN 1-12–Kneaded complex of nimesulide and cyclodextrin, NP–Nimesulide pure drug (unprocessed) and PT–Nimesulide pure drug in triturated 
form. The data is given as mean±SD (n=3) 
 
In vitro dissolution studies 
The in vitro dissolution study results of the various ratio of kneading 
method complex (NM-CD) are shown in fig. 3, 4 and 5. The 
unprocessed pure drug sample showed the very slow dissolution of 
less than 20% at the end of 60 min. In case of the pure drug in 
triturated (PT) form and also the kneaded mixture of drug: a carrier 
with no water (NW) content, the dissolution of the drug was poor. 
The data showed a significant increase in the percentage drug 
release with an increase in the water level of the formulation from 
25 to 50% w/v in all the three ratios of drug: carrier mixture (1:1, 
1:3 and 1:5). However, at 75% w/v water addition in the mixture, 
the dissolution of the drug was not varied notably which was due to 
the saturation solubility level of the drug: carrier mixture, as 
reported in the solubility study results. The results proved that the 
percentage of water added in the kneading mixture played a crucial 
role in the in vitro release of the drug from the mixture. Water helps 
to form a strong inclusion complex of drug with CDs at the optimum 
solvent concentration. Based on the results obtained, the 
formulation prepared with 50% w/v water level were considered as 
the optimum formulation and selected for further characterization 
studies. 
Fourier transforms infrared spectroscopy 
Infra red spectra of the pure drug and inclusion complexes of NM 
with β-CDs (1:1, 1:3 and 1:5) prepared by kneading method are 
given in fig. 6, 7, 8 and 9, respectively. The pure drug exhibited the 
characteristic peaks as the identity of the specific functional groups 
present in it. The sharp peaks observed at 3283 cm-1, 1589 cm-1, 
1153 cm-1 and 1273 cm-1 indicated the N-H stretching of amide, 
aromatic NO2 stretching, S=O stretching of sulphoxide and C-O-C 
stretching between the aromatic rings, respectively. Also, the 
presence of–CH3 and aromatic rings were confirmed by the 
corresponding stretching and bending vibrations. In case of all the 
kneaded inclusion complex samples (1:1, 1:3 and 1:5), the guest 
drug molecules present within the CDs cavity showed less intense 
peaks compared to the pure drug alone. The characteristic peaks of 
the drug were observed for the presence of N-H, NO2, S=O and C-O-C 
groups in the inclusion complex. The broad peak between the range 
of 3300 cm-1 and 3500 cm-1 showed the formation of intermolecular 
and intra molecular hydrogen bonding between the drug and β-CD 
[30-32]. These bonds were responsible for the mild interactions and 




Fig. 3: In vitro drug release profile of kneading complex of NM with CD at 1:1 ratio (n=3) 
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Fig. 4: In vitro drug release profile of kneading complex of NM with CD at 1:3 ratio (n=3) 
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Fig. 7: FTIR spectrum of kneaded complex of NM with CD at 1:1 ratio 
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Fig. 9: FTIR spectrum of kneaded complex of NM with CD at 1:5 ratio 
 
Thermal analysis 
NM and β-CDs complex prepared by the kneading method was 
subjected to TG-DTA analysis and the results are given in fig. 10 
and 11. Pure powder drug showed a sharp endothermic peak at 
150.10 °C, the characteristic melting point of the drug. Further 
increase in the temperature resulted in the exothermic peak at 
around 335 °C and a corresponding sudden weight loss in the TG 
curve at the same temperature, which indicated the decomposition 


















Fig. 10: Thermo gravimetric-differential thermal analysis of pure drug 
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Fig. 11: Thermo gravimetric-differential thermal analysis of NM-CD kneaded complex 
 
In case of the kneaded complex of drug: carrier, the endothermic 
peak of the drug was slightly shifted and hence the melting point 
was observed at 148.36 °C. The slight shift was probably due to a 
weak interaction between the host and guest molecules [31]. 
Additionally, the thermal properties of cyclodextrin were recorded, 
wherein the endothermic peat at around 82 °C represented the 
melting point of the polymer. Finally, the sample showed the 
decomposition temperature at 310 °C with corresponding sudden 
weight loss in the TG curve.  
Powder X-ray diffraction studies 
The XRD study results are displayed in fig. 12 and 13 for the pure 
drug and the kneaded complex formulation, respectively. The pure 
drug exhibited sharp peaks at 21.800, 22.740 and 23.260 with high 
intensity, which reflected the crystalline character of pure 
nimesulide. In case of the kneaded complex, the characteristics of 
both the drug and polymer were observed. Since the drug was 
encapsulated as inclusion complex in the carrier, the crystallinity of 
the drug was slightly altered. However, the sharp peaks in the 
formulated complex indicated the purity and crystal character of 




























Fig. 13: XRD pattern for kneaded complex of NM and CD (1:5 
ratio) 
CONCLUSION 
The solubility of the poorly aqueous soluble drug nimesulide was 
improved by the inclusion complex with β-cyclodextrin as a carrier. 
The effect of varying the percentage of water addition in the 
kneading process was comparatively explained. The formulation 
prepared with 50% w/v water addition exhibited a significant 
increase in the solubility and dissolution of the drug release. The 
flow and physical property of the prepared kneaded granules with 
improved angle of repose, tab density and Carr’s index confirmed 
the suitability of the mixture to convert into single unit solid dosage 
forms. The FTIR, TG-DTA and XRD studies confirmed the stability of 
the kneaded complex formulation without significant chemical 
alterations of the drug. The carrier compatibility and mild 
interactions in the formulation were also revealed. The formulated 
inclusion complex of nimesulide improved the solubility and flow 
properties to enhance the kinetic behaviour of the drug.  
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